Fischer Medical Ventures Ltd

Mon 24/08/2026,15:53:13 | NSE : FISCHER

₹36.47-1.67 (-4.38%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 38.14

Previous Close

₹ 38.14

Volume

1227530

Mkt Cap ( ₹ Cr)

₹ 2526.22

High

₹ 38.39

Low

₹ 35.70

52 Week High

₹ 124.70

52 Week Low

₹ 31.05

Book Value Per Share

₹ 5.68

Dividend Yield

0.00

Face Value

₹ 1.00

What's Your Call?

Collective community sentiment on Fischer Medical Ventures Ltd

Your Vote -

Buy

60.00%

Hold

20.00%

Sell

20.00%

60.00%

5 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

36.47

4051

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

4051

Option Chain

Analyzes market sentiment, predicts Fischer Medical Ventures Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Fischer Medical Vent has submitted to BSE the Shareholding Pattern for the Period Ended August 17, 2026

    21 Aug 2026, 5:20PM As of August 2026, 63.08% is owned by Promoters and 36.92% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 12.31% and For
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    24 Aug 2026, 2:54PM Fischer Medical Ventures Limited has informed the exchange on the press release titled \Catanduanes Integrated Digital Healthcare project Awarded to T
  • Fischer Medical Vent - General Updates

    17 Aug 2026, 6:11PM Fischer Medical Ventures Limited has informed the Exchange on the allotment of Equity shares pursuant to conversion of warrants
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Allotment

    17 Aug 2026, 5:57PM Allotment of equity shares pursuant to conversion of warrants
  • Fischer Medical Vent - Resignation of Director/KMP/SMP

    15 Aug 2026, 12:38PM Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP
  • Fischer Medical Vent - Resignation of Director/KMP/SMP

    15 Aug 2026, 12:34PM Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP
  • Fischer Medical Vent - General Updates

    14 Aug 2026, 9:14PM Fischer Medical Ventures Limited has informed the Exchange on allotment of Equity shares pursuant to conversion of warrants
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Allotment

    14 Aug 2026, 9:10PM Allotment of equity shares pursuant to conversion of warrants
  • Fischer Medical Vent - Financial Results For Q 1 FY 2026-27

    14 Aug 2026, 8:43PM Approval of Q 1 financial results for FY 2026-27
  • Fischer Medical Vent - Change in Director(s)

    14 Aug 2026, 8:37PM Fischer Medical Ventures Limited has informed the Exchange regarding Change in Director(s) of the company.
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Resignation of Director

    14 Aug 2026, 8:37PM Resgination of Independent Directors
  • Fischer Medical Vent - Board Meeting Outcome for Outcome Of Board Meeting

    14 Aug 2026, 8:32PM Approval of Q 1 financial results FY 2026-27 in alia, considered other matters.
  • Fischer Medical Vent - Outcome of Board Meeting

    14 Aug 2026, 8:31PM Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
  • Fischer Medical Vent - Monitoring Agency Report

    13 Aug 2026, 7:00PM Monitoring Agency Report for the quarter ended 30th June 2026
  • Fischer Medical Vent - General Updates

    13 Aug 2026, 6:58PM Fischer Medical Ventures Limited has informed the Exchange about about allotment of equity shares pursuant to conversion of warrants
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    13 Aug 2026, 6:50PM Monitoring Agency Report for quarter ended 30th June 2026
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Allotment

    13 Aug 2026, 6:40PM Allotment of equity shares pursuant to conversion of warrants
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Allotment

    12 Aug 2026, 6:56PM Allotment of Equity shares pursuant to Conversion of warrants.
  • Fischer Medical Vent - General Updates

    12 Aug 2026, 6:49PM Fischer Medical Ventures Limited has informed the Exchange about allotment of equity shares pursuant to conversion of warrants
  • Fischer Medical Vent - General Updates

    11 Aug 2026, 5:47PM Fischer Medical Ventures Limited has informed the Exchange about allotment of Equity shares pursuant to conversion of warrants
  • Fischer Medical Vent - Copy of Newspaper Publication

    11 Aug 2026, 11:06AM Fischer Medical Ventures Limited has informed the Exchange about Copy of Newspaper Publication
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Allotment

    11 Aug 2026, 5:40PM Allotment of 23,00,000 Equity shares pursuant to conversion of warrants
  • Fischer Medical Vent - Board Meeting Intimation for Approval Of Un-Audited Financial Results For Quarter Ended 30Th June 2026

    7 Aug 2026, 5:40PM Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to cons
  • Fischer Medical Vent - Press Release

    31 Jul 2026, 11:41AM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated July 31, 2026, titled ""Time Medical International Ventures
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    31 Jul 2026, 11:38AM Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fischer Medical Ventures Limited, announces partnership for Installa
  • Fischer Medical Vent - Press Release

    30 Jul 2026, 3:35PM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated July 30, 2026, titled ""Press Release on Fischer Medical Ve
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    30 Jul 2026, 3:24PM Fischer Medical Ventures Secures CDSCO Import Approval for Spincare- India's First Regulatory Clearance for a Portable Electrospun Wound Care System.
  • Fischer Medical Vent - Reply to Clarification- Financial results

    27 Jul 2026, 1:25PM The Exchange had sought clarification from Fischer Medical Ventures Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEB
  • Fischer Medical Vent has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    17 Jul 2026, 7:10PM As of June 2026, 62.15% is owned by Promoters and 37.85% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 11.46% and Forei
  • Fischer Medical Vent - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jul 2026, 12:30PM Fischer Medical Ventures Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Fischer Medical Vent - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2026, 12:26PM Certificate under Reg 74(5) of SEBI(DP) Regulations,2018 for quarter ended 30th June 2026
  • Fischer Medical Vent - Trading Window

    29 Jun 2026, 5:19PM Fischer Medical Ventures Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regu
  • Fischer Medical Vent - Copy of Newspaper Publication

    26 Jun 2026, 2:22PM Fischer Medical Ventures Limited has informed the Exchange about Copy of Newspaper Publication
  • Fischer Medical Vent - Newspaper Publication

    26 Jun 2026, 12:52PM Newspaper Publication for Share Transfer related
  • Fischer Medical Vent - Clarification - Financial Results

    25 Jun 2026, 10:57AM The Exchange has sought clarification from Fischer Medical Ventures Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEB
  • Fischer Medical Vent - Financial Results For The Quarter And Year Ended 31.03.2026

    31 May 2026, 10:44PM Financial Results for the Quarter and Year ended 31.03.2026
  • Fischer Medical Vent - Outcome of Board Meeting

    31 May 2026, 10:22PM Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.- Revised
  • Fischer Medical Vent - Outcome of Board Meeting

    30 May 2026, 3:28AM Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Fischer Medical Vent posts Q4 net loss of Rs 8.98 cr

    30 May 2026, 3:00PM The company reported standalone net loss during the quarter stood at Rs 8.98 crore as compared to net loss of Rs 0.89 crore in the previous year quart
  • Fischer Medical Vent - Corporate Action-Board approves Dividend

    30 May 2026, 3:05AM Recommendation of Final Dividend
  • Fischer Medical Vent - Finanacial Results

    30 May 2026, 2:00AM Financial Results
  • Fischer Medical Vent - Board Meeting Outcome for Oucome Of BM

    30 May 2026, 1:55AM Outcome of BM
  • Fischer Medical Vent - Board Meeting Intimation for Audit Financial Results Q4 And FY Ending 31St March 2026\r\n\r\n\r\n

    25 May 2026, 12:45PM Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to cons

Key fundamentals

Evaluate the intrinsic value of Fischer Medical Ventures Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 351.1019 335.685 79.6794 0.3057 0.1597
Liabilities 351.1019 335.685 79.6794 0.3057 0.1597
Equity 65.4515 63.8015 53.5 0.172 0.172
Gross Profit -8.6683 -2.2373 -0.1952 0.0152 -0.1887
Net Profit -10.4229 0.6632 0.4028 -0.0365 -0.2326
Cash From Operating Activities -5.7215 -24.1034 0.0796 -0.1459 -0.1769
NPM(%) -59.92 12.7 3.49 -20.33 0
Revenue 17.3918 5.2196 11.5283 0.1795 0
Expenses 26.0601 7.4569 11.7235 0.1643 0.1887
ROE(%) -2.64 0.16 0.1 0 -0.05

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Fischer Medical Ventures Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 1563.60 -1.33 13.75 34.45 1071.07 0.45
Sharda Cropchem Ltd 779.30 2.42 11.23 342.30 754.66 1.92
Amines and Plasticizers Ltd 188.91 -1.11 26.95 208.75 331.99 0.26
Indogulf Cropsciences Ltd 71.59 -1.68 11.74 185.10 63.31 0.00

Company Info

The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu. 2024-Fischer collaboration with Malaysia's Health Digital Technologies-Acquisition of 100% share capital stake in Time Medical International Ventures (India) Private Limited -The Company collaboration with Tech Avant- Garde  to enhance health programs in Indian Educational Institutions.-Fischer Medical Ventures Ltd & Voice - AI Company Wonder Tech Group Firm up Investment and Exclusive ASEAN, India & Middle East Marketing Rights2025-Time Medical International Ventures (I) P ltd, WOS of the Company announces the breakthrough new low field TOF MRI Platform for Aneurysm screening.-Nanomedic clears UK NHS Hurdle, Launches India Market Strategy and targets US FDA Submission-Fischer Medical Ventures' JV Partner NYB.AI Clinches Top Global AI Innovation Award-The Company Launch of Sikkim MRI Public - Private Partnership (PPP) project for Tuberculosis Diagnostic Screening Under Ayushman Bharat and NHM Schemes.

The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu. 2024-Fischer collaboration with Malaysia's Health Digital Technologies-Acquisition of 100% share capital stake in Time Medical International Ventures (India) Private Limited -The Company collaboration with Tech Avant- Garde  to enhance health programs in Indian Educational Institutions.-Fischer Medical Ventures Ltd & Voice - AI Company Wonder Tech Group Firm up Investment and Exclusive ASEAN, India & Middle East Marketing Rights2025-Time Medical International Ventures (I) P ltd, WOS of the Company announces the breakthrough new low field TOF MRI Platform for Aneurysm screening.-Nanomedic clears UK NHS Hurdle, Launches India Market Strategy and targets US FDA Submission-Fischer Medical Ventures' JV Partner NYB.AI Clinches Top Global AI Innovation Award-The Company Launch of Sikkim MRI Public - Private Partnership (PPP) project for Tuberculosis Diagnostic Screening Under Ayushman Bharat and NHM Schemes.

Parent Organisation

Fischer Medical Ventures Ltd.

Founded

22/03/1993

Managing Director

Mr.Ravindran Govindan

NSE Symbol

FISCHEREQ

FAQ